Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.6.3437

Serum Protein and Genetic Tumor Markers of Gastric Carcinoma  

He, Chao-Zhu (Department of Gastroenterology, the First Affiliated Hospital of Nanchang University / Jiangxi Institute of Gastroenterology and Hepatology)
Zhang, Kun-He (Department of Gastroenterology, the First Affiliated Hospital of Nanchang University / Jiangxi Institute of Gastroenterology and Hepatology)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.6, 2013 , pp. 3437-3442 More about this Journal
Abstract
The high incidence of gastric cancer and consequent mortality pose severe threats to human health. Early screening, diagnosis and treatment are the key to improve the prognosis of the patients with gastric cancer. Gastroscopy with biopsy is an efficient method for the diagnosis of early gastric cancer, but the associated discomfort and high cost make it difficult to be a routine method for screening gastric cancer. Serum tumor marker assay is a simple and practical method for detection of gastric cancer, but it is limited by poor sensitivity and specificity. Therefore, people have been looking for novel serum markers of gastric cancer in recent years. Here we review the novel serum tumor markers of gastric cancer and their diagnostic significance, focusing on the discoveries from serum proteomics analyses and epigenetics researches.
Keywords
Gastric cancer; serum tumor markers; screening and diagnosis;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Liu C, Pan C, Shen J, et al (2012). Identification of serum amyloid A in the serum of gastric cancer patients by protein expression profiling. Oncol Lett, 3, 1259-62.
2 Liu C, Xu L, Han HB, et al (2009). Preliminary study of serum protein fingerprint screening gastric cancer serum markers. Bases Clin Med, 16, 237-40
3 Wang YS, Shen J, Yu JK, et al (2008). Establish gastric high incidence of gastric cancer serum protein fingerprint diagnostic model. Zhonghua Yu Fang Yi Xue Za Zhi, 24, 677-80
4 Wang M, Li C, Nie H, et al (2012). Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK. FEBS Lett, 586, 2382-8.   DOI   ScienceOn
5 Rodriguez LG, Guan JL (2005). 14-3-3 regulation of cell spreading and migration requires a functional amphipathic groove. J Cell Physiol, 202, 285-94.   DOI   ScienceOn
6 Song J, Bai Z, Han W, et al (2012). Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig Dis Sci, 57, 897-904.   DOI   ScienceOn
7 Song MY, Pan KF, Su HJ, et al (2012). Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS One, 7, e33608.   DOI   ScienceOn
8 Sturgeon CM, Duffy MJ, Hofmann BR, et al (2010). National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Clin Chem, 56, e1-48.   DOI   ScienceOn
9 Tao HQ, He XJ, Ma YY, et al (2011). Evaluation of REG4 for early diagnosis and prognosis of gastric cancer. Hum Pathol, 42, 1401-9.   DOI   ScienceOn
10 Tsai KW, Liao YL, Wu CW, et al (2012). Aberrant expression of miR-196a in gastric cancers and correlation with recurrence. Genes Chromosomes Cancer, 51, 394-401   DOI   ScienceOn
11 Colarossi A, Inga R, Prochazka R, et al (2011). Pepsinogen and gastrin in the noninvasive diagnosis of gastric atrophy. A case-control study in Peruvian population. Rev Gastroenterol Peru, 31, 110-5.
12 Dilege E, Mihmanli M, Demir U, et al (2010). Prognostic value of preoperative CEA and CA 19-9 levels in resectable gastric cancer. Hepatogastroenterology, 57, 674-7.
13 Duraker N, Celik AN (2001). The prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma, comparison with CEA. J Surg Oncol, 76, 266-71.   DOI   ScienceOn
14 Deininger SO, Ebert MP, Fu¨ tterer A, et al (2008) MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers. J Proteome Res, 7, 5230-6.   DOI   ScienceOn
15 Mittal A, Poudel B, Pandeya DR, et al (2012). Serum amyloid a as an independent prognostic factor for renal cell carcinoma--a hospital based study from the Western region of Nepal. Asian Pac J Cancer Prev, 13, 2253-5.   과학기술학회마을   DOI   ScienceOn
16 Wu ZZ, Wang JG, Zhang XL (2009). Diagnostic model of saliva protein finger print analysis of patients with gastric cancer. World J Gastroenterol, 15, 865-70.   DOI
17 Xie X, Ma YT, Yang YN, et al (2010). Polymorphisms in the SAA1/2 gene are associated with carotid intima media thickness in healthy Han Chinese subjects: the Cardiovascular Risk Survey. PLoS One, 5, e13997.   DOI   ScienceOn
18 Xue WC, Feng K, Meng DY, et al (2009). Serum protein fingerprint for the early diagnosis of gastric cancer. J Pract Diagn Ther, 18, 153-6.
19 Yasuda H, Toiyama Y, Ohi M, et al (2011). Serum soluble vascular adhesion protein-1 is a valuable prognostic marker in gastric cancer. J Surg Oncol, 103, 695-9.   DOI   ScienceOn
20 Liu H, Zhu L, Liu B, et al (2012). Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett, 316, 196-203.   DOI   ScienceOn
21 Liu R, Zhang C, Hu Z, et al (2011). A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer, 47, 784-91.   DOI   ScienceOn
22 Liu W, Gao X, Cai Q, et al (2010). Identification of novel serum biomarkers for gastric cancer by magnetic bead. Front Biosci (Elite Ed), 2, 961-71.
23 Li W, Li JF, Qu Y, et al (2008). Comparative proteomics analysis of human gastric cancer. World J Gastroenterol, 14, 5657-64.   DOI
24 Li Y, Yang Y, Lu M, et al (2011). Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer. Hepatogastroenterology, 58, 2166-70.
25 Wang WJ, Liu CZ, Liu P, et al (2007). SELDI-TOF-MS technology screening gastric cancer serum markers. Environ Occup Med, 24, 143-6.
26 Tseng CW, Yang JC, Chen CN, et al (2011). Identification of 14-3-$3\beta$ in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker. Proteomics, 11, 2423-39.   DOI   ScienceOn
27 Umemura H, Togawa A, Sogawa K, et al (2011). Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis. J Gastroenterol, 46, 577-85.   DOI
28 Wang B, Zhang Q (2012). The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. J Cancer Res Clin Oncol, 138, 1659-66.   DOI   ScienceOn
29 Emoto S, Ishigami H, Yamashita H, et al (2012). Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination. Gastric Cancer, 15, 154-61.   DOI
30 Fang X, Tie J, Xie Y, et al (2010). Detection of gastric carcinomaassociated antigen MG7-Ag in human sera using surface plasmon resonance sensor. Cancer Epidemiol, 34, 648-51.   DOI   ScienceOn
31 Fukuda M, Yokozaki H, Shiba M, et al (2007) Genetic and epigenetic markers to identify high risk patients for multiple early gastric cancers after treatment with endoscopic mucosal resection. J Clin Biochem Nutr, 40, 203-9.   DOI   ScienceOn
32 Gomceli I, Bostanci EB, Ozer I, et al (2012). A novel screening biomarker in gastric cancer, serum dickkopf-1. Hepatogastroenterology, 59, 1661-4.
33 Hong L, Li S, Liu L, et al (2010) The value of MG7-Ag and COX-2 for predicting malignancy in gastric precancerous lesions. Cell Biol Int, 34, 873-6.   DOI   ScienceOn
34 Lu XX, Yu JL, Ying LS, et al (2012). Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression. Cancer, 118, 5507-17.   DOI   ScienceOn
35 Loei H, Tan HT, Lim TK, et al (2012). Mining the gastric cancer secretome, identification of GRN as a potential diagnostic marker for early gastric cancer. J Proteome Res, 11, 1759-72.   DOI   ScienceOn
36 Lu HB, Zhao CH, MaYY, et al (2006). The early gastric clinical significance of serum protein fingerprint diagnostic. Progress Mod Biomed, 11, 120-6
37 Lu HB, Zhou JH, Ma YY, et al (2010). Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer. Jpn J Clin Oncol, 40, 336-42.   DOI   ScienceOn
38 Wang M, Gu H, Wang S, et al (2012). Circulating miR-17-5p and miR-20a, molecular markers for gastric cancer. Mol Med Report, 5, 1514-20.
39 Wu C, Luo Z, Chen X, et al (2009). Two-dimensional differential in-gel electrophoresis for identification of gastric cancerspecific protein markers. Oncol Rep, 21, 1429-37.
40 Karpinski P, Myszka A, Ramsey D, et al (2011). Detection of viral DNA sequences in sporadic colorectal cancers in relation to CpG island methylation and methylator phenotype. Tumour Biol, 32, 653-9.   DOI   ScienceOn
41 Khoder G, Yamaoka Y, Fauche`re JL, et al (2009). Proteomic Helicobacter pylori biomarkers discriminating between duodenal ulcer and gastric cancer. J Chromatogr B Analyt Technol Biomed Life Sci, 877, 1193-9.   DOI   ScienceOn
42 Kobayashi Y, Niwa Y, Tajika M, et al (2010). Serum tumor antigen REG4 as a useful diagnostic biomarker in gastric cancer. Hepatogastroenterology, 57, 1631-4.
43 Liang Y, Pan CQ (2004). The chemical serum protein fingerprint model application in the diagnosis of gastric adenocarcinoma. Lab Med, 27, 122-6
44 Ren J, Chen Z, Juan SJ, et al (2000). Detection of circulating gastric carcinoma-associated antigen MG7-Ag in human sera using an established single determinant immuno-polymerase chain reaction technique. Cancer, 88, 280-5.   DOI
45 Iino C, Shimoyama T, Sasaki Y (2012). Influence of endoscopic submucosal dissection on serum levels of pepsinogens in patients with early gastric cancer. Dig Endosc, 24, 339-42.   DOI   ScienceOn
46 Irvani S, Hashemi MR, Moghadam KG, et al (2010). Accuracy of serum pepsinogens I and II, gastrin-17 and anti-helicobacter pylori antibodies in histological diagnoses of atrophic gastritis. Minerva Gastroenterol Dietol, 56, 13-7.
47 Qi Z. Li JF, Qu Y, et al (2007). Gastric cancer and adjacent tissue associated gene hypermethylation. Shanghai Jiaotong Univ Xue Bao (Medical Sciences), 27, 555-8.
48 Ahn HS, Shin YS, Park PJ, et al (2012). Serum biomarker panels for the diagnosis of gastric adenocarcinoma. Br J Cancer, 106, 733-9.   DOI   ScienceOn
49 Cao XY, Jia ZF, Jin MS, et al (2012). Serum pepsinogen II is a better diagnostic marker in gastric cancer. World J Gastroenterol, 18, 7357-61.   DOI   ScienceOn
50 Chae H, Lee JH, Lim J (2011). Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis. Korean J Lab Med, 28, 201-6.   과학기술학회마을   DOI   ScienceOn
51 Chan DC, Chen CJ, Chu HC, et al (2007). Evaluation of serum amyloid A as a biomarker for gastric cancer. Ann Surg Oncol, 14, 84-93.
52 Chen SZ (1992). The expression of MG7 corresponding antigen in gastrointestinal polyps and its relation with cancer. Zhonghua Wai Ke Za Zhi, 30, 716-8, 777-8.
53 Zheng Z, Li M, Zhang G, et al (2010). Identification of human gastric carcinoma biomarkers by differential protein expression analysis using (18)O labeling and NanoLC-MS/MS coupled with laser capture microdissection. Med Onco, 27, 296-303.   DOI   ScienceOn
54 Ychou M, Duffour J, Kramar A, et al (2000). Clinical significance and prognostic Value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Disease Markers, 16, 105-10.   DOI
55 Zhang BY, Yuan F, Xiao JC, et al (2010). 14-3-$3\zeta$ protein in gastric carcinoma and its significance. Shanghai Jiaotong Daxue Xue Bao, 30, 1129-32.
56 Zheng ZG, Xu SH, Xu Q, et al (2010). Use of serum protein profiling for early diagnosis of gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi, 13, 770-3.
57 Zheng Y, Cui L, Sun W, et al (2011). MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients. Cancer Biomark, 10, 71-7.
58 Zheng Y, Zhang Y, Huang X, et al (2011). Analysis of the RUNX3 gene methylation in serum DNA from esophagus squamous cell carcinoma, gastric and colorectal adenocarcinoma patients. Hepatogastroenterology, 58, 2007-11.
59 Zou XP, Zhang B, Zhang XQ, et al (2009). Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Hum Pathol. 40, 1534-42.   DOI   ScienceOn